MedTrace Logo

Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls

NCT04980807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-03-07

No results posted yet for this study

Summary

The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits.

The secondary aim is to collect information of different clinical and electrophysiological test procedures to perform possible future clinical trials in CMT patients.

Conditions

  • Charcot-Marie-Tooth Disease

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Ohio State University

    collaborator OTHER

  • NMD Pharma A/S

    lead INDUSTRY

Principal Investigators

  • Henning Andersen, MD, PhD · Aarhus University Hospital

  • William D Arnold, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-07
Primary Completion
2022-03-03
Completion
2022-03-03

Countries

  • United States
  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04980807 on ClinicalTrials.gov